Federal Register / Vol. 69, No. 235 / Wednesday, December 8, 2004 / Notices 71065

Dated: November 30, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26894 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Scientific and Technical 

Support for NIAID. 

Date: December 15, 2004. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817 (Telephone Conference 

Call). 

Contact Person: Robert C. Goldman, PhD, 

Scientific Review Administrator, Division of 

AIDS, NIH/NIAID/DAIDS/CCRB, Room 5226, 

6700–B Rockledge Drive, MSC 7624, 

Bethesda, MD 20892–7616. 

This notice is being published less than 15 

days prior to the meeting due to the urgent 

need to meeting timing limitations imposed 

by the intramural research review cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS)

Dated: November 30, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26896 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Allergy, Immunology, 

and Transplantation Research Committee, 

Allergy, Immunology and Transplantation 

Research Review Committee. 

Date: January 25–27, 2005. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Monterey, 1000 Aguajita 

Road, Monterey, CA 93940. 

Contact Person: Quirijn Vos. PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, National Institutes of Health/

NIAID, 6700B Rockledge Drive, MSC 7616, 

Bethesda, MD 20892–7616, (301) 451–2666, 

qvos@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS)

Dated: November 30, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26897 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of 

Informational Session 

The National Institute of Allergy and 

Infectious Diseases announces that an 

informational Session for individuals 

representing groups considering 

submission of applications in response 

to NIAID’s RFA number AI–04–045 

(http://grants.nih.gov/grants/guide/rfafiles/RFA-AI-04-045.html), entitled 

‘‘CENTERS FOR MEDICAL 

COUNTERMEASURES AGAINST 

RADIATION,’’ will be held on 

December 15, 2004, from 1 p.m. to 5 

p.m. e.s.t. 

The meeting will be held in Room 

2C–13, 10401 Fernwood Drive, 

Bethesda, MD 20817. Staff from the NIH 

Centers for Medical Countermeasures 

Against Radiation Program and from the 

Division of Extramural Activities will 

provide information about the Program 

and how to apply and will be available 

to answer questions pertinent to 

preparing applications in response to 

this RFA. Advance registration is not 

required. 

This meeting will also be available 

through a live broadcast allowing for 

questions from offsite locations. Please 

check http://videocast.nih.gov/

FutureEvents.asp for videocast 

information regarding this event. A 

videotape of the meeting will be made 

available for future viewing at http://

videocast.nih.gov/PastEvents.asp.

For questions or further information 

contact: Helen Quill, Ph.D., Basic 

Immunology Branch, Division of 

Allergy, Immunology and 

Transplantation, National Institute of 

Allergy and Infectious Diseases, Room 

3013, MSC–6601, 6610 Rockledge Drive, 

Bethesda, MD 20892–6601, telephone: 

301–496–7551, Fax: 301–480–2381, email: hquill@niaid.nih.gov.

Dated: November 30, 2004. 

Lynn C. Hellinger, 

Associate Director for Management and 

Operations, NIAID.

[FR Doc. 04–26900 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

71066 Federal Register / Vol. 69, No. 235 / Wednesday, December 8, 2004 / Notices 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Rehabilitative Sciences Ad Hoc Review 

Panel. 

Date: December 13, 2004. 

Time: 11 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jo Pelham, BA, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4102, MSC 7814, 

Bethesda, MD 20892, (301) 435–1786, 

pelhamj@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Neural Drug 

Development. 

Date: December 15, 2004. 

Time: 10:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Mary Custer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4148, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1164, custerm@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Dermal 

Absorption Special Emphasis Panel. 

Date: December 15, 2004. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Steve J. Zullo, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7849, Bethesda, MD 20892, (301) 435–

2810, zullost@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neurodegeneration Cystokeleton and 

Synaptic Function. 

Date: December 15, 2004. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Joanne T Fujii, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5204, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1178, fujiij@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

Dated: December 1, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26882 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice if hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

December 3, 2004, 10:30 a.m. to 

December 3, 2004, 11:30 a.m. National 

Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, which was 

published in the Federal Register

November 29, 2004, 69 FR 69379. 

The meeting will be held December 9, 

2004. The meeting time and location 

remain the same. The meeting is closed 

to the public.

Dated: December 1, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26884 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

November 16, 2004, 12 p.m. to 

November 16, 2004, 4 p.m., One 

Washington Circle Hotel, One 

Washington Circle, Washington, DC, 

20037 which was published in the 

Federal Register on November 3, 2004, 

69 FR 64078–64081. 

The meeting will be held December 

10, 2004. The meeting time and location 

remain the same. The meeting is closed 

to the public.

Dated: November 30, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26887 Filed 12–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Antibiotics. 

Date: December 1, 2004. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Marian Wachtel, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3208, 

MSC 7858, Bethesda, MD 20892, (301) 435–

1148, wachetlm@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, IVF and 

Genetic Testing. 

Date: December 3, 2004. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Lee S. Mann, PhD, 

Scientific Review Administrator, Center for